应用胶原凝胶构建组织工程化皮肤的研究

目的探讨以胶原凝胶为支架材料构建组织工程化皮肤的可行性。方法体外分离、培养人皮肤表皮细胞和成纤维细胞；利用自制的胶原蛋白制成胶原凝胶作为组织工程支架材料；在成功构建人工真皮的基础上种植表皮细胞，构建复合人工皮肤；采用HE染色与免疫组织化学的方法对复合人工皮肤进行组织学检测。结果HE染色可见，构建的复合人工皮肤具有表皮和真皮双层结构；免疫组织化学染色显示，Ⅳ型胶原、纤维连接蛋白和层粘连蛋白阳性，在形态结构上与正常皮肤相似。结论培养的人表皮细胞和成纤维细胞种植于胶原凝胶支架上，气一液界面培养可构建出具有类似正常皮肤结构的组织工程化皮肤。     

用含活性细胞的胶原支架复合皮修复小鼠全层皮肤缺损的研究

目的构建具有活性细胞成分的复合皮，观察其在修复小鼠全层皮肤缺损中的作用。方法将异种成纤维细胞种植于脱软骨细胞胶原支架上培养3d，形成真皮替代物。再将其放置于培养的上皮细胞膜上共同培养10d，组成含活性细胞成分的复合皮。将复合皮移植于小鼠的全层皮肤缺损处，记录其生长情况并于术后定期活检，进行组织学观察。结果胶原支架中可见生长良好的成纤维细胞和复层表皮细胞。移植术后1周，复合皮与小鼠缺损创面粘连紧密，可见明显的血管化。术后6周，创面愈合良好，移植物与创缘融合，未见明显排斥反应。结论以脱软骨细胞胶原为支架构建的复合皮，可作为皮肤替代物修复全层皮肤组织缺损。     

含内皮祖细胞的组织工程皮肤体外构建及裸鼠移植研究

目的构建含内皮祖细胞（EPC）和成纤维细胞的组织工程复合皮，初步研究EPC在组织工程皮肤移植中促血管发生的作用。方法采用免疫磁珠法从人脐血中分离培养CD133＋血管内皮祖细胞，以聚羟基乙酸（PGA）为真皮基质，接种EPC和成纤维细胞，其上覆盖表皮细胞膜片，构建组织工程复合皮，覆盖裸鼠背部全层皮肤缺损创面。结果EPC和成纤维细胞能均匀贴附于PGA支架纤维材料上，并逐渐伸展为梭形或多极状。裸鼠移植实验表职，实验组创面愈合早于对照组，可见EPC参与大量新生小血管形成，真皮支架5周完全降解。结论EPC参与血管重建，具有促进血管新生，加速缺血组织血管化的作用。应用PGA＋纤维蛋白凝胶，制备含EPC和成纤维细胞的活性真皮替代物，具有良好的生物相容性、降解特性。     

聚二元共聚物多孔支架活性真皮替代物的体外构建

活性皮肤替代物是指含有活细胞成分的皮肤组织工程产品 ,是皮肤组织工程研究的热点。由于人工合成的生物可降解材料具有生物相容性、加工性能良好以及降解速度可控等优点 ,已被广泛用作细胞支架。然而 ,在多孔的人工材料中种植细胞还存在很多问题。本文应用成纤维细胞胶原凝胶 (fibroblastspopulatedcollagenlattice ,FPCL)的制作方法 ,成功地将人成纤维细胞种植于聚二元共聚物 (乙交酯 /丙交酯polylacticacid/ polyglycolicacidcopolymers ,PLGA)多孔真皮支架中 ,体外培养出一种新型的活性真皮替代物。材　料　与　方　法1.胶原和细胞 …     

应用胶原凝胶构建组织工程化皮肤的研究

目的探讨以胶原凝胶为支架材料构建组织工程化皮肤的可行性。方法体外分离、培养人皮肤表皮细胞和成纤维细胞;利用自制的胶原蛋白制成胶原凝胶作为组织工程支架材料;在成功构建人工真皮的基础上种植表皮细胞,构建复合人工皮肤;采用HE染色与免疫组织化学的方法对复合人工皮肤进行组织学检测。结果HE染色可见,构建的复合人工皮肤具有表皮和真皮双层结构;免疫组织化学染色显示,Ⅳ型胶原、纤维连接蛋白和层粘连蛋白阳性,在形态结构上与正常皮肤相似。结论培养的人表皮细胞和成纤维细胞种植于胶原凝胶支架上,气-液界面培养可构建出具有类似正常皮肤结构的组织工程化皮肤。     

组织工程皮肤修复全层皮肤缺损的实验研究

目的 探索由人表皮干细胞、成纤维细胞与纤维蛋白支架构建的组织工程皮肤修复全层皮肤缺损的可行性. 方法 将人全层皮肤采用胰蛋白酶消化法使表皮干细胞和真皮成纤维细胞分离后,分别在无血清培养基中行原代及传代培养.将体外扩增培养至第3、4代的表皮干细胞(5×104/mL)和真皮成纤维细胞(1×104/mL)共0.5 mL与纤维蛋白支架(0.5 mL)混合凝固构建组织工程皮肤.取4～5周龄雄性裸鼠45只,体重19.5～20.3 g,平均20.0 g,制备背部全层皮肤缺损模型.随机分为5组,每组9只,分别为空白对照组(C组),创面仅覆盖凡士林油纱,自然愈合;单纯支架组(F组),创面移植无细胞的纤维蛋白支架;表皮支架组(S组),创面移植含有表皮干细胞的纤维蛋白支架复合物;成纤维细胞支架组(Fb组),创面移植含有成纤维细胞的纤维蛋白支架复合物;组织工程皮肤组(T组),创面移植组织工程皮肤.术前及术后1、3、6、8周行全身及移植部位大体观察;移植后3、6、8周,取材行组织学、免疫组织化学及扫描电镜观察. 结果 细胞培养4周后,表皮干细胞培养皿内可见圆形细胞,在加有BrdU的培养液中培养6 d后可见BrdU染色阳性细胞;成纤维细胞培养皿内可见梭形细胞.构建的组织工程皮肤可见CK19免疫荧光染色阳性细胞、Nestin染色阳性细胞.移植后T组新生皮肤较其余各组生长快、瘢痕轻.术后6周,C、F、S、Fb及T组皮肤厚度分别为(0.460 ±0.049)、(0.480 ±0.055)、(0.540 ±0.043)、(0.510 ±0.032)及(0.60 ±0.047)mm,T组明显厚于其余各组,且差异有统计学意义(P＜0.05).术后3、6、8周,HE染色及扫描电镜示,T组新生表皮层数及真皮成纤维细胞、血管数量均多于其余各组,且T组真皮血管及胶原纤维排列均较其余各组整齐;术后3周,Ⅳ型胶原免疫组织化学染色显示,T组已形成连续的染色带,而其余各组均不连续;术后6周,CK14免疫组织化学染色显示,T组可见阳性细胞,其余各组均未见. 结论 用表皮干细胞、成纤维细胞及纤维蛋白支架构建的组织工程皮肤移植后能使创面迅速愈合,可望成为一种较理想的组织工程皮肤.     

组织工程口腔黏膜固有层修复皮肤缺损的初步研究

目的探讨两种组织工程口腔黏膜固有层移植修复皮肤缺损的效果.方法分别以胶原凝胶和壳多糖-胶原凝胶为网架与体外培养的Wistar大鼠口腔黏膜成纤维细胞构建胶原凝胶口腔黏膜固有层(fibroblast-populated collagen lattice,FPCL)、壳多糖-胶原凝胶口腔黏膜固有层(fibroblast -populated chitosan collagen lattice,FPCCL),用BrdU标记其中的成纤维细胞后,移植修复同种异体大鼠背部全层皮肤圆形缺损.将36只21～25周龄Wistar大鼠分为FPCL组、FPCCL组及创口仅覆盖纱布的对照组,每组12只.术后行大体观察创面愈合情况;4、7、14和21 d 3组创面直径测量;组织学及免疫组织化学染色观察其组织修复情况.结果术后大鼠创面均无感染,创面结痂在14及17 d自然脱落,创面逐渐愈合,被新生表皮覆盖,术后21 d新生皮肤光滑,颜色与正常皮肤接近,无体毛.术后各时间点3组创面直径均逐渐变小,差异有统计学意义(P＜0.01),14 d以后,创口大小较稳定.术后7 d,FPCL组受植创面比FPCCL组受植创面和对照组创面小(P＜0.01).组织学观察:术后7 d,3组创面未完全表皮化;14、21 d,FPCL组、FPCCL组受植区完全表皮化,有钉突,对照组无明显钉突,表皮已分层,基底细胞层完整,最表面有角化物;真皮中新生胶原纤维细,含毛细血管.免疫组织化学染色显示,FPCL组、FPCCL组术后各时间点阳性成纤维细胞出现在肉芽组织的细胞密集处和新生真皮中,与新生肉芽组织共同参与了皮肤缺损的修复重建,未出现免疫排斥现象.结论口腔黏膜成纤维细胞作为修复皮肤缺损的种子细胞是可行和有效的,壳多糖胶原凝胶在限制受植区创面收缩变小方面优于单纯胶原凝胶.FPCL和FPCCL两组新生皮肤的质量优于对照组,两种组织工程口腔黏膜固有层作为皮肤缺损区永久性真皮替代物是可行和有效的.     

组织工程人工血管支架的预构

目的：探讨具有血管平滑肌细胞（vascular smooth muscle cells,VSMCs）活性的组织工程人工血管支架的构建方法。方法：①将聚羟基乙酸（polyglycolic acid,PGA）纤维无纺网支架材料、血管平滑肌细胞和胶原纤维相混合，构建组织工程血管。②将VSMCs置入胶原凝胶中，观察VSMCs的生长状况。③观察VSMCs胶原悬液滴入该支架材料中的生长。结果：①VSMCs在胶原凝胶中的位置固定，分布于不同层次，约3－4h逐渐形成多个胞质突起。随时间推移，胞质突起继续伸展，部分细胞呈梭形、纺锤形。②VSMCs胶原悬液滴入胶原包埋处理的PGA支架中后，大部分细胞随胶原凝胶状态的形成，滞留于支架材料网孔中，细胞可沿PGA纤维表面生长。结论：胶原包埋处理的PGA纤维无纺网是良好的携带VSMCs的多孔生物降解材料。     

壳多糖基质网架复层组织工程皮肤的移植研究

目的 探讨组织工程皮肤动物移植实验的效果。方法 应用以壳多糖为基质网架构建的组织工程化复层人工皮肤，对裸鼠大面积(直径20mm)全层皮肤缺损模型进行移植修复。24只8周龄裸鼠分为组织工程皮肤移植(AS)组、壳多糖膜覆盖物(CH)组及对照组，术后进行大体观察，并在3、7、14和21天应用组织学、红外热像扫描分析等手段对修复组织进行动态监泅。结果 AS组在移植第3天，组织工程皮肤与自体皮肤能够很好地融合，有少量毛细血管长入移植物，皮肤移植钧颜色与自体皮肤颜色接近；随着时间的延长，移植物中毛细血管的数量逐渐增多，表皮层清晰可见基底层、棘细胞层、颗粒层和角质层，角化征象加强，有角化物脱落；真皮层细胞数量增多，网架逐渐降解，分泌的细胞外基质成分增多；第14天，创面基本愈合，修复区皮肤颜色与正常皮肤颜色非常接近，短痕小，无需进行二次植皮。CH组至移植第14天，结痂未完全脱落，创面未愈合，颜色较AS组深；第21天创面愈合，遗留较大短痕，与正常皮肤区分明显，而对照组的结痴脱落，创面大而深，颜色深红。结论 以壳多糖为基质网架构建的组织工程化皮肤具有良好的组织相容性，可应用于皮肤缺损的移植修复。     

椎间盘组织工程支架材料研究进展

目的 综述椎间盘组织工程支架材料及其应用的研究现状。方法 广泛查阅近年来有关椎间盘组织工程支架材料及其应用的文献，进行综述。结果 琼脂糖凝胶、藻酸盐凝胶、Ⅰ型胶原以及聚羟基乙酸和聚乳酸等仍然是目前椎间盘组织工程的主要支架材料，均具有较好的生物相容性。结论 研究开发具有良好性能的支架材料仍是椎间盘组织工程研究的热点和难点之一。     

Clinical experience with collagenous wound dressing in severe traumatic soft tissue injuries]

We treated 34 patients during 1987-1990 with a collagen wound dressing. Eleven patients had traumatic soft tissue defects, 10 patients had 3 degrees-grade open fractures, 7 patients had infected soft tissue wounds and 6 patients had deep 2 degrees and 3 degrees-degree burns. Our clinical experience confirmed the excellent clinical experimental results of collagen wound dressings. In all cases after 4 until 6 days of treatment good granulation and vascularisation of the wound bed was obtained, so that a skin transplant could be performed, which in all cases healed primarily. Moreover, the wound dressing had a good antibacterial effect and integrated actively in the wound healing process.     

组织工程化表皮膜片构建及其在供皮区的应用研究

目的构建组织工程化表皮细胞膜片并应用于供皮区创面治疗。方法利用患者少量自体或同种异体正常皮肤分离、培养、扩增的表皮细胞,接种于壳聚糖明胶膜构建成表皮细胞膜片;将膜片移植于治疗组供皮区创面、适度加压,同时设立对照组:空白材料对照以及传统油纱布对照覆盖创面。于术后5～10d、30d、90d行大体观察、组织学检查、广谱角蛋白、外皮蛋白、层粘连蛋白、免疫组织化学检测以及Ⅰ、Ⅲ型胶原比值测定(偏光显微镜、RTPCR)。结果利用自体及异体表皮细胞和壳聚糖明胶膜能够构建出人表皮细胞膜片,应用于临床供皮区创面治疗15例,经过3个月随访,疗效肯定。移植膜片创面愈合时间(8.1±1.3)d,空白材料对照区为(16.2±3.8)d,空白油纱布对照区为(23.0±5.8)d。移植膜片存活良好,结构较完整、术后30d及90d观察:12例无明显增生,3例有轻度增生(20.0%),而空白油纱布对照区11例遗留增生性瘢痕(74.4%,χ2=8.127,P<0.01)。结论表皮细胞-壳聚糖明胶膜片能促进供皮区创面早期愈合并减少后期瘢痕增生,具有良好治疗效果。     

重组人表皮生长因子促进大鼠皮肤创面愈合的研究

目的观察重组人表皮生长因子(rhEGF)对皮肤创面愈合的作用。方法制作大鼠背部创伤模型,采用自身平行对照,将34只大鼠背部的68个创面分成rhEGF治疗组与盐水对照组,观察大体形态和组织学改变、创面愈合时间和愈合率,测定伤后不同时间创面羟脯氨酸(OHP)含量和Ⅰ型Ⅲ型胶原比例,进行细胞DNA周期分析。结果经rhEGF治疗的创面愈合速度较盐水对照明显加快,2组平均愈合时间为(17.2±1.3)d和(20.5±1.6)d(P<0.01);外用rhEGF使创面肉芽组织生成增多,再上皮化明显,显著增加创面中OHP含量,降低Ⅰ型Ⅲ型胶原比例,加速细胞DNA复制。结论外用rhEGF可缩短创面愈合时间,增加肉芽组织及OHP含量,降低Ⅰ型Ⅲ型胶原比例,加速细胞DNA复制,明显促进皮肤创面的修复。     

023 Development of Tissue Engineering Skin Based on Acellular Dermal Matrix

Aim: In tissue engineering of the skin, the selection of a scaffold or a matrix in which a cultured cells grow is quite important. We have developed a tissue engineering skin composed of human keratinocytes and fibroblasts on an acellular allogenic dermal matrix (ADM), derived from cryopreserved human skin. Methods: ADM was prepared from cryopreserved split‐thickness human skin by treating with Dispase and Triton X‐100. The tissue engineering skin were produced by seeding human keratinocytes and fibroblasts on ADM. Several days after seeding, the tissue engineering skin was exposed to an air‐liquid interface for another 7 days. Then, the histological structure of the skin and the production of growth factors by the skin were investigated. Results: The produced ADM was found to be completely acellular with remaining structure of the basement membrane components, such as type IV collagen and laminin. The developed tissue engineering skin had stratified keratinocytes on the surface of the ADM migrating fibroblasts in the dermal collagen structure, resembling to the normal skin appearance. It was found that several important growth factors in wound healing process, such as TGF‐α, TGF‐β and VEGF, were produced by the tissue engineering skin. Conclusions: It was suggested that ADM is suitable for a scaffold in tissue engineering of the skin.     

Successful treatment of complex traumatic and surgical wounds with a foetal bovine dermal matrix

A foetal bovine dermal repair scaffold (PriMatrix, TEI Biosciences) was used to treat complex surgical or traumatic wounds where the clinical need was to avoid skin flaps and to build new tissue in the wound that could be reepithelialised from the wound margins or closed with a subsequent application of a split‐thickness skin graft (STSG). Forty‐three consecutive cases were reviewed having an average size of 79·3 cm², 50% of which had exposed tendon and/or bone. In a subset of wounds (44·7%), the implantation of the foetal dermal collagen scaffold was also augmented with negative pressure wound therapy (NPWT). Complete wound healing was documented in over 80% of the wounds treated, whether the wound was treated with the foetal bovine dermal scaffold alone (95·2%) or when supplemented with NPWT (82·4%). The scaffold successfully incorporated into wounds with exposed tendon and/or bone to build vascularised, dermal‐like tissue. The new tissue in the wound supported STSGs however, in the majority of the cases (88·3%); wound closure was achieved through reepithelialisation of the incorporated dermal scaffold by endogenous wound keratinocytes. The foetal bovine dermal repair scaffold was found to offer an effective alternative treatment strategy for definitive closure of challenging traumatic or surgical wounds on patients who were not suitable candidates for tissue flaps.     

Collagen tightening induced by carbon dioxide laser versus erbium: YAG laser

BACKGROUND AND OBJECTIVE: Pulsed CO2 laser resurfacing improves photodamage and acne scarring by ablation of abnormal tissue with subsequent regeneration and remodeling of collagen and through heat induced collagen contraction. Whether collagen contraction persists long-term and helps maintain the skin tightening observed after resurfacing is debated. One possible mechanism of long-term clinical tightening is that of wound contracture that occurs as part of normal wound healing. If normal wound contracture, and not heat induced collagen contraction, is responsible for maintaining the initial skin tightening seen in CO2 laser resurfacing, then equal results would be expected from resurfacing with either CO2 or erbium lasers. The study was performed to determine whether there is a difference in skin tightening secondary to thermally mediated collagen contraction versus that which occurs secondary to tissue contraction of wound healing. The persistence of these changes over 6 months and the histologic characteristics were studied as well. STUDY DESIGN/MATERIALS AND METHODS: Nine patients had four tattoo dots applied to the upper eyelids, with horizontal axis measuring 18-20 mm and the vertical axis 6-10 mm. One month later, one eyelid was treated with three passes of the UltraPulse CO2 laser and the other eyelid with an erbium laser to the end point of early pinpoint bleeding. Three patients were treated with additional passes after pinpoint bleeding was encountered. The total number of pulses used per patient was recorded. Measurements of the vertical and horizontal distances were made after each pass and monthly for 6 months. The treated skin was then excised in performance of an upper lid blepharoplasty and the tissue submitted for histologic analysis. RESULTS: In the vertical plane, the UltraPulse CO2 laser induced an average of 43% tightening intraoperatively and this gradually diminished to an average of 34% by 6 months, whereas the wound contracture of erbium resurfacing was not seen until 1 month postoperatively, at which time 42% tightening was seen, gradually diminishing to 36% at 6 months. Three patients with erbium resurfacing had scarring present. These were the three patients treated most aggressively and also the three patients with the most significant wound contracture. Scarring was not seen on the CO2 treated side in any patients. In the horizontal plane, the CO2 laser caused 31% intraoperative tightening, decreasing to 19% at 6 months. In this plane, the erbium laser induced wound contracture was 12% at 1 month which remained stable and unchanged. CONCLUSIONS: Although wound contraction secondary to tissue healing may result in nearly the same tissue tightening as heat-induced collagen contraction, the two processes are very different and variable, with increased risk of scarring seen with wound contracture, compared with heat-induced collagen tightening. The tissue tightening seen with thermally induced collagen contraction is long-lasting, if not "permanent."     

The wound healing potential of collagen peptides derived from the jellyfish Rhopilema esculentum

Purpose: Wound represents a major health challenge as they consume a large amount of healthcare resources to improve patient''s quality of life. Many scientific studies have been conducted in search of ideal biomaterials with wound-healing activity for clinical use and collagen has been proven to be a suitable candidate biomaterial. This study intended to investigate the wound healing activity of collagen peptides derived from jellyfish following oral administration. Methods: In this study, collagen was extracted from the jellyfish–Rhopilema esculentum using 1% pepsin. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and fourier transform infrared (FTIR) were used to identify and determine the molecular weight of the jellyfish collagen. Collagenase II, papain and alkaline proteinase were used to breakdown jellyfish collagen into collagen peptides. Wound scratch assay (in vitro) was done to determine migration potential of human umbilical vein endothelial cells (HUVEC) covering the artificial wound created on the cell monolayer following treatment with collagen peptides. In vivo studies were conducted to determine the effects of collagen peptides on wound healing by examining wound contraction, re-epithelialization, tissue regeneration and collagen deposition on the wounded skin of mice. Confidence level (p < 0.05) was considered significant using GraphPad Prism software. Results: The yield of collagen was 4.31%. The SDS-PAGE and FTIR showed that extracted collagen from jellyfish was type I. Enzymatic hydrolysis of this collagen using collagenase II produced collagen peptides (CP1) and hydrolysis with alkaline proteinase/papain resulted into collagen peptides (CP2). Tricine SDSPAGE revealed that collagen peptides consisted of protein fragments with molecular weight <25 kDa. Wound scratch assay showed that there were significant effects on the scratch closure on cells treated with collagen peptides at a concentration of 6.25 mg/mL for 48 h as compared to the vehicle treated cells. Overall treatment with collagen peptide on mice with full thickness excised wounds had a positive result in wound contraction as compared with the control. Histological assessment of peptides treated mice models showed remarkable sign of re-epithelialization, tissue regeneration and increased collagen deposition. Immunohistochemistry of the skin sections showed a significant increase in b-fibroblast growth factor (b-FGF) and the transforming growth factor-b1 (TGF-b1) expression on collagen peptides treated group. Conclusion: Collagen peptides derived from the jellyfisheRhopilema esculentum can accelerate the wound healing process thus could be a therapeutic potential product that may be beneficial in wound clinics in the future.     

在胶原海绵膜上构建人表皮细胞和成纤维细胞复合移植物的实验研究

目的将原代培养的人表皮细胞和成纤维细胞，接种到一种新的载体-胶原海绵膜上，构建新的复合皮肤替代物。方法来源于人包皮的表皮细胞和成纤维细胞分别原代培养，成纤维细胞经消化后接种在胶原海绵膜上(1×10     

血小板衍生生长因子对成纤维细胞合成胶原的影响

目的 探讨血小板衍生生长因子（ＰＤＧＦ－ＡＢ）促进伤口愈合的作用机理及其在瘢痕增生中的作用。方法 取体外培养的人正常皮肤及增生性瘢痕成纤维细胞,用原位杂交法观察ＰＤＧＦ对两种细胞表达Ｐｒｏα１（Ⅲ）ｍＲＮＡ的影响。结果;ＰＤＧＦ－ＡＢ对两种成纤维细胞表达Ｐｒｏ α１（Ⅲ）ｍＲＮＡ均有明显促进作用,且均呈剂量依赖性关系,但作用有差异。     

A novel recombinant human collagen hydrogel as minced split-thickness skin graft overlay to promote full-thickness skin defect reconstruction

To overcome limited donor-site availability in patients with extensive burns, split-thickness skin grafts (STSGs) are sometimes minced into micrografts (MGs) to improve the expansion ratio of the grafts, but this may reduce wound healing. We aimed to produce a novel hydrogel as an overlay of minced STSGs to improve wound healing. The new hydrogel was produced using recombinant human collagen type III powder as a raw material. Morphological and physical characteristics (degradation and swelling rate), cytotoxicity, and cell viability of the hydrogel were evaluated in vitro. A full-thickness in vivo skin defect model was constructed with male Sprague-Dawley rats. The animals were randomly assigned to experimental and control groups in which the new hydrogel and Vaseline gauze, respectively, were overlaid on minced STSGs to repair and regenerate skin wound. The healing rates and recovery status were compared between the two groups. The hydrogels exhibited good water retention properties and a suitable degradation rate, which can promote the proliferation and migration of wound healing-related cells in vitro. Further, using the hydrogel as an overlay accelerated wound closure and angiogenesis, increased dermal tissue and basement membrane formation, enhanced collagen synthesis and wound healing-related growth factor expression, while reducing scar formation compared to the Vaseline gauze group. In conclusion, the novel, low-cost recombinant human collagen hydrogel can accelerate wound closure and improve wound healing when used as an overlay of minced STSGs. The new hydrogel could become a new treatment option for traumatic skin wounds caused by burns or injuries.